NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 53 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q1 2017. The put-call ratio across all filers is 5.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $180,000 | +0.6% | 780,000 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $179,000 | -36.3% | 780,000 | 0.0% | 0.01% | -43.8% |
| Q1 2018 | $281,000 | -14.3% | 780,000 | 0.0% | 0.02% | -23.8% |
| Q4 2017 | $328,000 | 0.0% | 780,000 | 0.0% | 0.02% | -22.2% |
| Q3 2017 | $328,000 | -17.6% | 780,000 | 0.0% | 0.03% | -15.6% |
| Q2 2017 | $398,000 | -13.5% | 780,000 | 0.0% | 0.03% | -20.0% |
| Q1 2017 | $460,000 | -35.8% | 780,000 | -30.4% | 0.04% | -60.8% |
| Q4 2016 | $717,000 | +40.6% | 1,120,000 | +9.8% | 0.10% | +47.8% |
| Q3 2016 | $510,000 | +28.8% | 1,020,000 | +41.7% | 0.07% | +46.8% |
| Q2 2016 | $396,000 | – | 720,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|